Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Therapy”

397 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 397 results

Testing effectiveness (Phase 2)Looking for participantsNCT05983107
What this trial is testing

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Who this might be right for
HR+/HER2- Advanced Breast CancerTargeted Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Testing effectiveness (Phase 2)Study completedNCT01592500
What this trial is testing

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Who this might be right for
Pediatric Growth Hormone Deficiency
OPKO Health, Inc. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Not applicableStudy completedNCT06830525
What this trial is testing

Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology

Who this might be right for
Growth Hormone Deficiency (GHD)
Luis Fernandez Luque 40
Testing effectiveness (Phase 2)Looking for participantsNCT05355272
What this trial is testing

Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)

Who this might be right for
Gulf War SyndromeAdult Growth Hormone Deficiency
Baylor College of Medicine 20
Not applicableStudy completedNCT01897753
What this trial is testing

Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age

Who this might be right for
Small For Gestational Age (SGA)
Pfizer 264
Testing effectiveness (Phase 2)UnknownNCT06470672
What this trial is testing

Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Advanced Breast CancerHormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Fudan University 32
Large-scale testing (Phase 3)Ended earlyNCT00630487
What this trial is testing

Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Pfizer 9
Testing effectiveness (Phase 2)Study completedNCT02616562
What this trial is testing

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in Children
Novo Nordisk A/S 76
Not applicableStudy completedNCT02015286
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 7
Not applicableUnknownNCT00187993
What this trial is testing

Growth Hormone Treatment of Young Growth Hormone-Deficient Adults

Who this might be right for
Growth Hormone Deficiency
University Hospital, Angers 30
Not applicableStudy completedNCT02015273
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 82
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Post-approval studies (Phase 4)Study completedNCT00929799
What this trial is testing

Growth Hormone and Glucose Metabolism

Who this might be right for
Growth Hormone Deficiency
Charite University, Berlin, Germany 6
Not applicableStudy completedNCT00443144
What this trial is testing

D3-GHR Polymorphism and Turner Syndrome

Who this might be right for
Turner SyndromeShort Stature
University Hospital Tuebingen
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Large-scale testing (Phase 3)Study completedNCT00813189
What this trial is testing

Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

Who this might be right for
Chronic DiseaseGlucocorticoid Therapy, Response toGrowth Retardation
Association REMEDE 30
Testing effectiveness (Phase 2)Ended earlyNCT05176080
What this trial is testing

Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Henan Cancer Hospital 46
Not applicableStudy completedNCT00006143
What this trial is testing

Growth Hormone Treatment of Children With HIV-Associated Growth Failure

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 102
Post-approval studies (Phase 4)Study completedNCT00376064
What this trial is testing

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 20
Next Page